Moore David Scott
SEC insider (Form 3/4/5 filer). CIK 0002088466. Director at Corvus Pharmaceuticals, Inc. (CRVS). 3 reported Form 4/5 transactions since Sep 2024; latest on Jun 11, 2026. Located in SOUTH SAN FRANCISCO, CA.
Companies Moore David Scott has filed insider reports for
- Corvus Pharmaceuticals, Inc. (CRVS): Director
Moore David Scott
CIK: 0002088466
Transaction Breakdown
Open Market Buys (P)1 (33.3%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)2 (66.7%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
CRVS
Corvus Pharmaceuticals, Inc.
Director
Discretionary Trading P&L
Holdings
Transaction History (3 total)
- Jun 11, 2026CRVS
Corvus Pharmaceuticals, Inc.
PurchaseDirect21.7K shares at avg. $11.53$250K - Jun 11, 2026CRVS
Corvus Pharmaceuticals, Inc.
AwardDirectStock Option (Right to Buy)
15K shares- - Oct 2, 2025CRVS
Corvus Pharmaceuticals, Inc.
AwardDirectStock Option (Right to Buy)
30K shares-
1-3 of 3 transactions